In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pathogenica Inc.

Latest From Pathogenica Inc.

Pathogenica Inc.

Pathogenica, co-founded by Harvard's George Church, PhD, views itself as an "apps" company for a variety of human genome sequencing platforms. Its BioDetection system has the potential to screen thousands of samples, each tested for hundreds of unique pathogen strains at a predicted cost of less than one dollar per pathogen. The start-up aims to enable effective and affordable pathogen sequencing in a wide range of markets - physician, veterinary, and farming - not just scientific.

Start-Up Previews (10/2010)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Eyeing New Drugs For Glaucoma," features profiles of Altheos, Amakem and Mimetogen Pharmaceuticals. Plus these Start-Ups Across Health Care: Aragon Surgical, Arcarios, Carolina BioPharm, Miromatrix Medical and Pathogenica.
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Services
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pathogenica Inc.
  • Senior Management
  • Yemi Adesokan, PhD, CEO
    Graeme Doran, PhD, CSO
    John Boyce, Co-Dir., Bus. Dev.
    Jessica Tonani, Co-Dir., Bus. Dev.
  • Contact Info
  • Pathogenica Inc.
    Phone: (617) 444-8458
    245 First St.
    18th Fl.
    Cambridge, MA 02142